Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pilot Therapeutics

This article was originally published in The Tan Sheet

Executive Summary

Company acquires majority ownership of New York-based food distributor Interallied Group Sept. 5; will change name traded on NASDAQ OTC bulletin board to Pilot Therapeutics. Pilot plans to launch medical food Airozin - a leukotriene antagonist asthma product to be manufactured at DPT Labs in San Antonio - in first half of 2002. Radio and print ads will break approximately three months before launch, with professional campaign targeting asthma doctors and general campaign reaching the public. Saratoga Springs, N.Y.-based advertising firm Palio Communications will oversee the promotional campaign
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS093018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel